Hashem Haghdoost yazdi - Search Results

Year	Number of Results
2007	1
2008	1
2010	2
2011	1
2012	4
2013	2
2014	2
2015	1
2016	1
2017	2
2018	3
2019	1
2021	4
2022	5
2024	3
2025	1
2026	0

1

Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta.

Sarbazi-Golezari A, Haghdoost-Yazdi H. Sarbazi-Golezari A, et al. Among authors: haghdoost yazdi h. Metab Brain Dis. 2022 Feb;37(2):373-381. doi: 10.1007/s11011-021-00868-4. Epub 2021 Nov 12. Metab Brain Dis. 2022. Retraction in: Metab Brain Dis. 2024 Mar;39(3):483. doi: 10.1007/s11011-023-01298-0. PMID: 34767157 Retracted.

2

Blockage of ventrolateral periaqueductal gray matter cannabinoid 1 receptor increases dental pulp pain and pain-related subsequent learning and memory deficits in rats.

Raoof M, Sofiabadi M, Haghdoost-Yazdi H, Kooshki R, Abbasnejad M. Raoof M, et al. Among authors: haghdoost yazdi h. Behav Pharmacol. 2022 Apr 1;33(2&3):165-174. doi: 10.1097/FBP.0000000000000566. Behav Pharmacol. 2022. PMID: 32483053

3

Unraveling the function and structure impact of deleterious missense SNPs in the human OX1R receptor by computational analysis.

Farajzadeh-Dehkordi M, Mafakher L, Harifi A, Haghdoost-Yazdi H, Piri H, Rahmani B. Farajzadeh-Dehkordi M, et al. Among authors: haghdoost yazdi h. Sci Rep. 2024 Jan 8;14(1):833. doi: 10.1038/s41598-023-49809-4. Sci Rep. 2024. PMID: 38191899 Free PMC article.

4

Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.

Haghdoost-Yazdi H, Piri H, Najafipour R, Faraji A, Fraidouni N, Dargahi T, Alipour Heidari M. Haghdoost-Yazdi H, et al. Neurosciences (Riyadh). 2017 Jan;22(1):44-50. doi: 10.17712/nsj.2017.1.20160266. Neurosciences (Riyadh). 2017. PMID: 28064330 Free PMC article.

5

Trehalose and carnosic acid induced LC3I, LC3II ratio, P62 down-regulation and cleaved caspase 3 expression in neural stem cells.

Haghdoost-Yazdi H, Abbaszadeh HA, Hamidabadi HG, Darabi S, Darabi L, Rajaei F, Bakhtiyari S. Haghdoost-Yazdi H, et al. Bratisl Lek Listy. 2022;123(12):901-907. doi: 10.4149/BLL_2022_144. Bratisl Lek Listy. 2022. PMID: 36342878

6

Dopaminergic neuronal death in the substantia nigra associates with change in serum levels of TNF-α and IL-1β; evidence from early experimental model of Parkinson's disease.

Piri H, Sharifi S, Nigjeh S, Haghdoost-Yazdi H. Piri H, et al. Among authors: haghdoost yazdi h. Neurol Res. 2022 Jun;44(6):544-553. doi: 10.1080/01616412.2021.2024726. Epub 2022 Jan 5. Neurol Res. 2022. PMID: 34986749

7

Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease.

Sophiabadi M, Rastgoo N, Haghdoost-Yazdi H. Sophiabadi M, et al. Among authors: haghdoost yazdi h. Biol Trace Elem Res. 2022 Sep;200(9):4058-4067. doi: 10.1007/s12011-021-03012-6. Epub 2021 Nov 6. Biol Trace Elem Res. 2022. Retraction in: Biol Trace Elem Res. 2025 Mar;203(3):1788. doi: 10.1007/s12011-024-04247-9. PMID: 34741694 Retracted.

8

Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease.

Farzam SA, Darabi S, Haghdoost-Yazdi H, Zaferani Y. Farzam SA, et al. Among authors: haghdoost yazdi h. Neurol Res. 2024 Aug;46(8):763-771. doi: 10.1080/01616412.2024.2354084. Epub 2024 May 13. Neurol Res. 2024. PMID: 38740025

9

Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

Haghdoost-Yazdi H, Faraji A, Fraidouni N, Movahedi M, Hadibeygi E, Vaezi F. Haghdoost-Yazdi H, et al. Behav Brain Res. 2011 Sep 30;223(1):70-4. doi: 10.1016/j.bbr.2011.04.021. Epub 2011 Apr 21. Behav Brain Res. 2011. PMID: 21540059

10

Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.

Esmaeili MH, Movahedi M, Faraji A, Haghdoost-Yazdi H. Esmaeili MH, et al. Among authors: haghdoost yazdi h. Neurotoxicol Teratol. 2012 Sep-Oct;34(5):489-94. doi: 10.1016/j.ntt.2012.07.001. Epub 2012 Jul 9. Neurotoxicol Teratol. 2012. PMID: 22789434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year